Kazda C - Search Results

1

The European Exenatide study of long-term exenatide vs. glimepiride for type 2 diabetes: rationale and patient characteristics.

Kazda C, Gallwitz B, Simó R, Guzmán JR, Kraus P, Nicolay C, Rose L, Schernthaner G. Kazda C, et al. Diabetes Obes Metab. 2009 Dec;11(12):1131-7. doi: 10.1111/j.1463-1326.2009.01091.x. Epub 2009 Sep 16. Diabetes Obes Metab. 2009. PMID: 19758357

2

Prandial insulin substitution with insulin lispro or insulin lispro mid mixture vs. basal therapy with insulin glargine: a randomized controlled trial in patients with type 2 diabetes beginning insulin therapy.

Kazda C, Hülstrunk H, Helsberg K, Langer F, Forst T, Hanefeld M. Kazda C, et al. J Diabetes Complications. 2006 May-Jun;20(3):145-52. doi: 10.1016/j.jdiacomp.2005.09.004. J Diabetes Complications. 2006. PMID: 16632233 Clinical Trial.

3

Impact of postprandial and fasting glucose concentrations on HbA1c in patients with type 2 diabetes.

Schernthaner G, Guerci B, Gallwitz B, Rose L, Nicolay C, Kraus P, Kazda C. Schernthaner G, et al. Among authors: kazda c. Diabetes Metab. 2010 Nov;36(5):389-94. doi: 10.1016/j.diabet.2010.04.004. Epub 2010 Jul 2. Diabetes Metab. 2010. PMID: 20598608 Clinical Trial.

4

Contribution of insulin deficiency and insulin resistance to the development of type 2 diabetes: nature of early stage diabetes.

Gallwitz B, Kazda C, Kraus P, Nicolay C, Schernthaner G. Gallwitz B, et al. Among authors: kazda c. Acta Diabetol. 2013 Feb;50(1):39-45. doi: 10.1007/s00592-011-0319-4. Epub 2011 Aug 23. Acta Diabetol. 2013. PMID: 21861172

5

Evaluation of Efficacy and Safety of the Glucagon Receptor Antagonist LY2409021 in Patients With Type 2 Diabetes: 12- and 24-Week Phase 2 Studies.

Kazda CM, Ding Y, Kelly RP, Garhyan P, Shi C, Lim CN, Fu H, Watson DE, Lewin AJ, Landschulz WH, Deeg MA, Moller DE, Hardy TA. Kazda CM, et al. Diabetes Care. 2016 Jul;39(7):1241-9. doi: 10.2337/dc15-1643. Epub 2015 Dec 17. Diabetes Care. 2016. PMID: 26681715 Clinical Trial.

6

Treatment with the glucagon receptor antagonist LY2409021 increases ambulatory blood pressure in patients with type 2 diabetes.

Kazda CM, Frias J, Foga I, Cui X, Guzman CB, Garhyan P, Heilmann C, Yang JA, Hardy TA. Kazda CM, et al. Diabetes Obes Metab. 2017 Aug;19(8):1071-1077. doi: 10.1111/dom.12904. Epub 2017 Mar 27. Diabetes Obes Metab. 2017. PMID: 28191913 Clinical Trial.

7

Treatment with LY2409021, a glucagon receptor antagonist, increases liver fat in patients with type 2 diabetes.

Guzman CB, Zhang XM, Liu R, Regev A, Shankar S, Garhyan P, Pillai SG, Kazda C, Chalasani N, Hardy TA. Guzman CB, et al. Among authors: kazda c. Diabetes Obes Metab. 2017 Nov;19(11):1521-1528. doi: 10.1111/dom.12958. Epub 2017 Jun 8. Diabetes Obes Metab. 2017. PMID: 28371155 Free article. Clinical Trial.

8

Ultra rapid lispro (URLi) shows accelerated pharmacokinetics and greater reduction in postprandial glucose versus Humalog® in patients with type 1 diabetes mellitus in a randomized, double-blind meal test early-phase study.

Kazda C, Leohr J, Liu R, Reddy S, Dellva MA, Loh MT, Hardy T, Plum-Mörschel L. Kazda C, et al. Diabetes Obes Metab. 2022 Feb;24(2):196-203. doi: 10.1111/dom.14563. Epub 2021 Oct 24. Diabetes Obes Metab. 2022. PMID: 34595812 Free PMC article. Clinical Trial.

9

Ultra-rapid lispro shows faster pharmacokinetics and reduces postprandial glucose excursions versus Humalog® in patients with type 2 diabetes mellitus in a randomized, controlled crossover meal test early phase study.

Leohr J, Kazda C, Liu R, Reddy S, Dellva MA, Matzopoulos M, Loh MT, Hardy T, Klein O, Kapitza C. Leohr J, et al. Among authors: kazda c. Diabetes Obes Metab. 2022 Feb;24(2):187-195. doi: 10.1111/dom.14561. Epub 2021 Oct 27. Diabetes Obes Metab. 2022. PMID: 34605142 Free PMC article. Clinical Trial.

10

Impact of insulin on microvascular blood flow and endothelial cell function in the postprandial state in patients with Type 1 diabetes.

Forst T, Forst S, Strunk K, Löbig M, Welter K, Kazda C, Pfützner A. Forst T, et al. Among authors: kazda c. J Diabetes Complications. 2005 May-Jun;19(3):128-32. doi: 10.1016/j.jdiacomp.2004.09.002. J Diabetes Complications. 2005. PMID: 15866056 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

23 results

Search Page

Filters